Inhibitory effects of tranilast on expression of transforming growth factor-β isoforms and receptors in injured arteries

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 267-275

  Ward, Michael R ^a   Sasahara, Takayuki ^a   Agrotis, Alex ^a   Dilley, Rodney J ^a   Jennings, Garry L ^a   Bobik, Alex ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angioplasty; Integrins; Restenosis; TGF receptors; TOF s; Tranilast

Indexed keywords

INTEGRIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; TRANILAST; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, BALLOON; ANIMALS; ANTHRANILIC ACIDS; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTEGRINS; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET AGGREGATION INHIBITORS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032055716     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00275-X     Document Type: Article

References (39)

1. Nikol S., Isner J.M., Pickering G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592.
2. Ueda H., Imazu M., Sumil K., Yamamoto H., Ono K., Tadehara F., Hayashi Y., Yasui W., Yamakido M. Association of transforming growth factor-beta isoforms with coronary plaque in patients with coronary ischaemia. J Am Coll Cardiol. 29(Supp I):1997;155A.
3. 1 expression is significantly increased in saphenous vein graft with multiple versus single restenosis events (Abstract). Circulation. 86(Supp I):1992;I-21.
4. 1 during repair of arterial injury. J Clin Invest. 88:1991;904-910.
5. Nabel E.G., Shum L., Pompili V.J., Yang Z.-Y., San H., Shu H.B., Liptay S., Gold L., Gordon D., Derynck R., Nabel G.J. Direct transfer of transforming growth factor-β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA. 90:1993;10759-10763.
6. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 93:1994;1172-1178.
7. Kenzaki T., Tamura K., Takahashi K., Saito Y., Akikusa B., Oohashi H., Kasayuki N., Ueda M., Morisaki N. In vivo effect of TGF-β1. Enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol. 15:1995;1951-1957.
8. Wysocki S.J., Zheng M.-H., Fan Y., Lamawansa M.D., House A.K., Norman P.E. Expression of transforming growth factor-β1 (TGF-β1) and urokinase-type plasminogen activator (u-PA) genes during arterial repair in the pig. Cardiovasc Res. 31:1996;28-36.
9. Kim S., Kawamura M., Wanibuchi H., Ohta K., Hamaguchi A., Omura T., Yukimura T., Miura K., Iwao H. Angiotensin II type I receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation. 92:1995;88-95.
10. The TREAT Study Investigators The impact of tranilast on restenosis following coronary angioplasty: the Tranilast Restenosis Following Angioplasty Trial (TREAT). Circulation. 90:1994;I-652.
11. The TREAT-2 Study Investigators The impact of tranilast on restenosis following coronary angioplasty: the second Tranilast Restenosis Following Angioplasty Trial (TREAT 2). Circulation. 94:1996;I-620.
12. Hsu Y.-S., Tamai H., Ueda K., Ono S., Kosuga K., Tanaka S., Matsui S., Motohara S., Uehata H. Efficacy of tranilast on restenosis after coronary stenting. Circulation. 94:1996;I-620.
13. Tanaka K., Honda M., Kuramochi T., Morioka S. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Atherosclerosis. 107:1994;179-185.
14. 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneous hypertensive rats. Atherosclerosis. 118:1995;213-221.
15. Brown S.L., Lundgren C.H., Nordt T., Fujii S. Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. Cardiovasc Res. 28:1994;1815-1820.
16. Janat M.F., Argraves W.S., Liau G. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor-β1 and by platelet-derived growth factor-BB. J Cell Physiol. 151:1992;588-595.
17. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. Lab Invest. 49:1983;327-333.
18. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid Guanidinium Thiocyanate-Phenol-Chloroform extraction. Anal Biochem. 162:1987;152-159.
19. Wong J., Rauhoft C., Dilley R., Agrotis A., Jennings G.L., Bobik A. Angiotensin converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates their proliferation in injured carotid arteries. Relationship to neointima formation. Circulation. 96:1997;1631-1640.
20. Ward M., Agrotis A., Kanellakis P., Dilley R., Jennings G., Bobik A. Inhibition of protein tyrosine kinases attenuate increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury. Arterioscler Thromb Vasc Biol. 17:1997;2461-2470.
21. 1→S progression. J Cell Sci. 107:1994;227-239.
22. Qian S.W., Kondiah P., Roberts A.B., Sporn M.B. cDNA cloning by PCR of rat transforming growth factor β-1. Nucl Acids Res. 18:1990;3059.
23. Wang J., Kuliszewski M., Yee W., Sedlackova L., Xu J., Tseu I., Post M. Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblasts. J Biol Chem. 270:1995;2722-2728.
24. He W.W., Gustafson M.L., Hirobe S., Donahoe P. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev Dyn. 196:1993;133-142.
25. Tsuchida K., Mathews L.S., Vale W.W. Cloning and characterisation of a transmembrane serine kinase that acts as an activin type I receptor. Proc Natl Acad Sci USA. 90:1993;11242-11246.
26. Tsuchida K., Lewis K.A., Mathews L.S., Vale W.W. Molecular characterisation of rat transforming growth factor-β type II receptor. Biochem Biophys Res Commun. 191:1993;790-795.
27. 3 integrin subunits in rat osteoclasts in situ. J Bone Min Res. 8:1993;403-414.
28. Hemmerich P., von Mikecz A., Neumann F., Sozeri O., Wolff-Vorbeck G., Zoebelein R., Krawinkel U. Structural and functional properties of ribosomal protein L7 from humans and rodents. Nucl Acids Res. 21:1993;223-231.
29. Little P.J., Cragoe E.J., Bobik A. Na-H exchange is a major pathway for Na influx in rat vascular smooth muscle. Am J Physiol. 251:1986;C707-C712.
30. --dependent mechanism. Circ Res. 67:1990;814-825.
31. Lastres P., Letamendia A., Zhang H., Rius C., Almendro N., Raab U., Lopez L.A., Lang C., Fabra A., Letarte M., Bernabeu C. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol. 133:1996;1109-1121.
32. 1-receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK-90. Int J Cancer. 54:1993;862-867.
33. Koyama N., Koshikawa T., Morisaki N., Saito Y., Yoshida S. Bifunctional effects of transforming growth factor-β on migration of cultured smooth muscle cells. Biochem Biophys Res Commun. 169:1990;725-729.
34. Agrotis A., Saltis J., Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 23:1994;593-599.
35. Yamashita H., ten Dijke P., Franzen P., Miyazono K., Heldin C.-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β J Biol Chem. 269:1994;20172-20178.
36. Lin H.Y., Moustakis A. TGF-β receptors: structure and function. Cell Mol Biol. 40:1994;337-349.
37. McCaffrey T.A., Consigli S., Du B., Falcone D.J., Sanborn T.A., Spokojny A.M., Bush H.L. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. J Clin Invest. 96:1995;2667-2675.
38. O'Brien E.R., Bennett K.L., Garvin M.R., Zderic T.W., Hinohara T., Simpson J.B., Kimura T., Noboyushi M., Mizgala H., Purchio A., Schwartz S.M. βig-h3, a transforming growth factor-β-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol. 16:1996;576-584.
39. Topol E.J., Califf R.M., Weisman H.F., Ellis S.J., Tcheng T.E., Worley S., Ivanhoe R., George B.S., Fintel D., Weston M. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 343:1994;881-886.